Ilya Rachman - Aug 14, 2023 Form 4/A - Amendment Insider Report for Immix Biopharma, Inc. (IMMX)

Role
CEO and Chairman, Director
Signature
/s/ Ilya Rachman
Stock symbol
IMMX
Transactions as of
Aug 14, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
11/9/2023, 07:54 PM
Date Of Original Report
Aug 14, 2023
Previous filing
Aug 14, 2023
Next filing
May 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMMX Stock Options Award $0 +293K $0.00 293K Aug 14, 2023 Common Stock 293K $1.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest monthly over 48 months from the date of grant.